Dezhan Healthcare Co

Dezhan Healthcare Co Gross Margin

The Gross Margin of Dezhan Healthcare Co (000813.SZ) as of Nov 5, 2026 is 56.15 %. In the previous year, Gross Margin was 63.47 % — a change of -11.53% (lower).

Gross Margin

56.15 %

YoY

-11.53%

Last updated:

Gross Margin of Dezhan Healthcare Co is 2025 56.15 % . Gross Margin of Dezhan Healthcare Co was 2024 63.47 % . It decreases by -11.53% lower compared to the previous year.

Dezhan Healthcare Co's gross margin stands at 56.2%, down from 64.4% several years earlier.

The Dezhan Healthcare Co Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
92.54 CNY
Jan 1, 2019
78.86 CNY
Jan 1, 2020
69.43 CNY
Jan 1, 2021
64.41 CNY
Jan 1, 2022
37.03 CNY
Jan 1, 2023
55.20 CNY
Jan 1, 2024
63.47 CNY
Jan 1, 2025
56.15 CNY
The Dezhan Healthcare Co Gross Margin history
YEARGross MarginYoY
56.15 %-11.53%
63.47 %+14.98%
55.20 %+49.06%
37.03 %-42.50%
64.41 %-7.23%
69.43 %-11.97%
78.86 %-14.78%
92.54 %+2.95%
89.89 %+6.31%
84.55 %-0.11%
84.65 %+2.92%
82.25 %+4,875.54%
1.65 %-33.51%
2.49 %+1,110.57%
0.21 %-26.76%
0.28 %+137.65%
0.12 %-22.55%
0.15 %-10.91%
0.17 %-4.80%
0.18 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Dezhan Healthcare Co Stock analysis

What does Dezhan Healthcare Co do? Dezhan Healthcare Co., Ltd. generates revenue through the development and sale of cardiovascular and cerebrovascular drugs, anti-cancer drugs, health care products, functional beverages, and ecological water. The company's subsidiaries produce injections, biopharmaceuticals, and Chinese medicine preparations to optimize product structures and meet diverse market demands. Its primary market is China, where it targets consumers seeking health and wellness solutions through pharmaceutical and functional beverage offerings. The firm focuses on human life sciences research, emphasizing cardiovascular and cerebrovascular drugs, anti-cancer drugs, health care products, functional beverages, and ecological water. Subsidiaries introduce production lines for multiple dosage forms, including injections, biopharmaceuticals, and Chinese medicine preparations, to enhance product variety and meet specific consumer needs within the Chinese market. Sales are driven by the domestic demand for health-focused pharmaceutical and beverage products. Dezhan Healthcare Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dezhan Healthcare Co stock

Gross Margin of Dezhan Healthcare Co is 56.15 % in 2025.

Gross Margin of Dezhan Healthcare Co changed from 63.47 % to 56.15 %, representing a -11.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Dezhan Healthcare Co since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Dezhan Healthcare Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Dezhan Healthcare Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Dezhan Healthcare Co